Bill Text: NY A09603 | 2017-2018 | General Assembly | Introduced

---

Bill Title: Requires that in state offices with ten or more full time staff present, one staff member shall be required to be trained in the administration of opioid antagonists.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2018-01-25 - referred to governmental operations [A09603 Detail]

Download: New_York-2017-A09603-Introduced.html

---

                STATE OF NEW YORK
        ________________________________________________________________________
                                          9603
                   IN ASSEMBLY
                                    January 25, 2018
                                       ___________
        Introduced  by  M.  of  A. D. ROSENTHAL -- read once and referred to the
          Committee on Governmental Operations
        AN ACT to amend the executive law and the public health law, in relation
          to requiring staff members of state offices with ten or  more  members
          to be trained in the administration of opioid antagonists
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
     1    Section 1. The executive law is amended by adding a new section 171 to
     2  read as follows:
     3    § 171. Opioid antagonist training and use. 1. Definitions. As used  in
     4  this section, the following terms shall have the following meanings:
     5    (a)  "Opioid"  means  an  opiate  as defined in   section thirty-three
     6  hundred two of the public health law.
     7    (b) "Opioid antagonist" means a federal food and drug  administration-
     8  approved  drug  that, when administered, negates or neutralizes in whole
     9  or in part the pharmacological effects of an opioid  in  the  body.  The
    10  opioid  antagonist  is limited to naloxone or other medications approved
    11  by the department of health for this purpose.
    12    2. In state offices with ten or more  full  time  staff  present,  one
    13  staff  member  shall  be required to be trained in the administration of
    14  opioid antagonists.
    15    3. Such staff member shall:
    16    (a) complete an  initial  training  program,  which  may  include  any
    17  department  of  health  approved  opioid  overdose  prevention  training
    18  program;
    19    (b) complete a refresher training program at least every two years;
    20    (c) contact the emergency medical system  during  any  response  to  a
    21  victim  of suspected drug overdose and advise if an opioid antagonist is
    22  being used;
    23    (d) comply with protocols for response to victims  of  suspected  drug
    24  overdose; and
    25    (e)  report all responses to victims of suspected drug overdose to the
    26  department of health.
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD14272-01-8
        A. 9603                             2
     1    4. The costs of training and purchasing opioid  antagonists  shall  be
     2  paid  for out of the department of health's grant established by Centers
     3  for Disease Control and Prevention.
     4    5.  Use  of  an  opioid  antagonist  pursuant to this section shall be
     5  considered first aid or emergency treatment for the purpose of any stat-
     6  ute relating to liability pursuant to section thirty-three hundred  nine
     7  of the public health law.
     8    §  2.  The public health law is amended by adding a new section 3000-e
     9  to read as follows:
    10    § 3000-e. Opioid antagonist training and use. 1. Definitions. As  used
    11  in this section, the following terms shall have the following meanings:
    12    (a)  "Opioid"  means  an  opiate  as  defined  in section thirty-three
    13  hundred two of this chapter.
    14    (b) "Opioid antagonist" means a federal food and drug  administration-
    15  approved  drug  that, when administered, negates or neutralizes in whole
    16  or in part the pharmacological effects of an opioid  in  the  body.  The
    17  opioid  antagonist  is limited to naloxone or other medications approved
    18  by the department of health for this purpose.
    19    2. In state offices with ten or more  full  time  staff  present,  one
    20  staff  member  shall  be required to be trained in the administration of
    21  opioid antagonists.
    22    3. Such staff member shall:
    23    (a) complete an  initial  training  program,  which  may  include  any
    24  department  of  health  approved  opioid  overdose  prevention  training
    25  program;
    26    (b) complete a refresher training program at least every two years;
    27    (c) contact the emergency medical system  during  any  response  to  a
    28  victim  of suspected drug overdose and advise if an opioid antagonist is
    29  being used;
    30    (d) comply with protocols for response to victims  of  suspected  drug
    31  overdose; and
    32    (e)  report all responses to victims of suspected drug overdose to the
    33  department of health.
    34    4. The costs of training and purchasing opioid  antagonists  shall  be
    35  paid  for out of the department of health's grant established by Centers
    36  for Disease Control and Prevention.
    37    5. Use of an opioid antagonist  pursuant  to  this  section  shall  be
    38  considered first aid or emergency treatment for the purpose of any stat-
    39  ute  relating to liability pursuant to section thirty-three hundred nine
    40  of this chapter.
    41    § 3. This act shall take effect one year after it shall have become  a
    42  law.